95629-02-0

Basic information

• Product Name: 3-BROMO-4-OXO-PIPERIDINE-1-CARBOXYLIC ACID ETHYL ESTER
• Synonyms: 3-BROMO-4-OXO-PIPERIDINE-1-CARBOXYLIC ACID ETHYL ESTER;ETHYL 3-BROMO-4-OXO-PIPERIDINE-1-CARBOXYLATE;N-Carboethoxy-3-Bromo-4-Piperidone;1CARBETHOXY-3-BRONO-4-PIPERIDONE;1CARBETHOXY-3-BROMO-4-PIPERIDONE;3-Bromo-4-oxo-piperidine-1-caroboxylic acid ethyl ester;1-Piperidinecarboxylic acid, 3-broMo-4-oxo-, ethyl ester;3-bromo-4-oxo-1-ethoxycarbonyl-piperidine
• CAS NO: 95629-02-0
• Molecular Formula: C₈H₁₂BrNO₃
• Molecular Weight: 250.09
• Mol File: 95629-02-0.mol

Chemical Properties

• Boiling Point: 320.161 °C at 760 mmHg
• Flash Point: 147.428 °C
• Appearance: /
• Density: 1.539g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.529
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 3-BROMO-4-OXO-PIPERIDINE-1-CARBOXYLIC ACID ETHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 3-BROMO-4-OXO-PIPERIDINE-1-CARBOXYLIC ACID ETHYL ESTER(95629-02-0)
• EPA Substance Registry System: 3-BROMO-4-OXO-PIPERIDINE-1-CARBOXYLIC ACID ETHYL ESTER(95629-02-0)

Safety Data

• Hazardous Substances Data: 95629-02-0(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
3-Bromo-4-oxo-piperidine-1-carboxylic acid ethyl ester is used as a building block in organic synthesis for the creation of a variety of piperidine derivatives. Its unique structure and reactivity allow for the development of new compounds with potential applications in various fields.
Used in Pharmaceutical Research:
In Pharmaceutical Research, 3-Bromo-4-oxo-piperidine-1-carboxylic acid ethyl ester is used as a precursor in the production of pharmaceuticals. Its chemical properties make it a promising candidate for the development of biologically active compounds with potential therapeutic applications.
Used in Agrochemical Production:
3-Bromo-4-oxo-piperidine-1-carboxylic acid ethyl ester is also used as a potential precursor in the production of agrochemicals. Its reactivity and chemical properties enable the synthesis of compounds that can be utilized in the development of pesticides and other agricultural chemicals to improve crop protection and yield.
Overall, 3-Bromo-4-oxo-piperidine-1-carboxylic acid ethyl ester is a versatile chemical compound with applications in organic synthesis, pharmaceutical research, and agrochemical production, making it an important component in the development of innovative and effective products across these industries.

InChI:InChI=1/C8H12BrNO3/c1-2-13-8(12)10-4-3-7(11)6(9)5-10/h6H,2-5H2,1H3

Upstream product

• 29976-53-2 N-ethoxycarbonyl-4-piperidone 
• 7789-45-9 copper(II)bromide 

Downstream Products

• 623932-10-5 ethyl 3-{[(3-ethoxycarbonyl)-1H-pyrazol-5-yl]oxy}-4-oxopiperidine-1-carboxylate 
• 83898-43-5 ethyl 3-hydroxy-4,4-dimethoxy-1-piperidinecarboxylate 
• 1206612-18-1 2-[4-(4-methoxycarbonyl-phenyl)-tetrahydro-pyran-4-yl]-6,7-dihydro-4H-thiazolo[5,4-c]pyridine-5-carboxylic acid ethyl ester 
• 1206611-98-4 C₂₀H₂₄N₂O₅S 
• 1363281-30-4 5-(cyclopropylacetyl)-4,5,6,7-tetrahydro-2-(phenoxymethyl)-oxazolo[5,4-c]pyridine 
• 1363281-33-7 5-(3,5-difluorobenzoyl)-4,5,6,7-tetrahydro-2-(phenoxymethyl)-oxazolo[5,4-c]pyridine 
• 1363282-10-3 2-(phenoxymethyl)-5-(trifluoroacetyl)-4,5,6,7-tetrahydro[1,3]oxazolo[5,4-c]pyridine 
• 1363286-16-1 2-(1,2-dihydroxy-2-phenylethyl)-6,7-dihydro-oxazolo[5,4-c]pyridine-5(4H)-carboxylic acid ethyl ester 
• 1363286-25-2 ethyl 2-(phenoxymethyl)-6,7-dihydro-4H-oxazolo[5,4-c]pyridine-5-carboxylate 
• 1363286-28-5 2-(phenoxymethyl)-4,5,6,7-tetrahydrooxazolo[5,4-c]pyridine 
• 1363281-27-9 (4-fluorophenyl)-[2-(phenoxymethyl)-6,7-dihydro-4H-oxazolo[5,4-c]pyridin-5-yl]methanone 
• 1363286-13-8 6,7-dihydro-2-[(E)-2-phenylethenyl]-oxazolo[5,4-c]pyridine-5(4H)-carboxylic acid ethyl ester 
• 1190971-76-6 tert-butyl 2-(hydroxymethyl)-6,7-dihydrothiazolo[5,4-c]pyridine-5(4H)-carboxylate 
• 1190970-39-8 2-[[(2S)-1-[(4-methoxy-2,6-dimethyl-phenyl)sulfonyl]-piperidin-2-yl]-methoxy]-1-[2-(piperidin-1-yl-methyl)-4,5,6,7-tetrahydro-thiazolo[5,4-c]pyridin-5-yl]-ethanone 

Relevant articles and documents

Further optimization of the mGlu5 PAM clinical candidate VU0409551/JNJ-46778212: Progress and challenges towards a back-up compound

This Letter describes the progress and challenges in the continued optimization of the mGlu5 positive allosteric modulator (PAM) clinical candidate VU0490551/JNJ-46778212. While many analogs addressed key areas for improvement, no one compound possessed the amalgamation of improvements needed within the (2(phenoxymethyl)-6,7-dihydrooxazolo[5,4-c]pyridine-5(4H)-yl(aryl)methanone scaffold to advance as a back-up clinical candidate. However, many analogs displayed excellent solubility and physiochemical properties, and were active in the amphetamine-induced hyperlocomotion (AHL) model. Moreover, the SAR was robust for this series of PAMs, and both polar and hydrogen-bond donors were found to be tolerated, leading to analogs with overall attractive profiles and good ligand efficiencies. Graphical abstract

BICYCLIC OXAZOLE AND THIAZOLE COMPOUNDS AND THEIR USE AS ALLOSTERIC MODULATORS OF MGLUR5 RECEPTORS

In one aspect, the invention relates to novel bicyclic oxazole and thiazole compounds which are positive allosteric modulators of the metabotropic glutamate receptor subtype 5 ("mGluR5"); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; methods of treating neurological and psychiatric disorders associated with glutamate dysfunction using the compounds and compositions; and methods for the treatment or prevention of disorders associated with glutamate dysfunction and diseases in which the mGluR5 subtype of receptors is involved. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

SUBSTITUTED SULFONAMIDE DERIVATIVES

The invention relates to substituted sulfonamide derivatives, processes for the preparation thereof, medicaments containing these compounds and the use of substituted sulfonamide derivatives for the preparation of medicaments.

Dynamic kinetic resolution allows a highly enantioselective synthesis of cis-α-aminocycloalkanols by ruthenium-catalyzed asymmetric hydrogenation

(Chemical Equation Presented) Resolutely dynamic hydrogenation: A highly efficient asymmetric hydrogenation of racemic N,N-disubstituted α-aminocycloalkanones involving dynamic kinetic resolution in the presence of a ruthenium catalyst gives chiral α-aminocycloalkanols with excellent enantioselectivities and cis diastereoselectivities (see scheme). A synthesis of optically pure U-(-)-50488 based on this reaction is reported.

N-acylamino acid amide compounds and intermediates for preparation thereof

The present invention discloses the compound represented by the formula (I): wherein A represents the following formula (a-1) or the following formula (a-2): B represents the following formula (b): (wherein the symbols are each as defined in the specification) or a pharmaceutically acceptable salts thereof, and intermediates for the preparation thereof, which have excellent platelet aggregation inhibitory activity and other properties and useful as prophylactic or therapeutic agents for diseases associated with a fibrinogen receptor, thrombosis, infarction and the like.

Novel N-(3-hydroxy-4-piperidinyl)benzamide derivatives

Novel N-(3-hydroxy-4-piperidinyl)benzamides and derivatives thereof, said compounds being useful as stimulators of the motility of the gastro-intestinal system.